238 related articles for article (PubMed ID: 17110336)
1. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.
Le Cam L; Linares LK; Paul C; Julien E; Lacroix M; Hatchi E; Triboulet R; Bossis G; Shmueli A; Rodriguez MS; Coux O; Sardet C
Cell; 2006 Nov; 127(4):775-88. PubMed ID: 17110336
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
3. A new function for p53 ubiquitination.
Hirano Y; Ronai Z
Cell; 2006 Nov; 127(4):675-7. PubMed ID: 17110328
[TBL] [Abstract][Full Text] [Related]
4. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
Tang Y; Luo J; Zhang W; Gu W
Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
[TBL] [Abstract][Full Text] [Related]
5. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
6. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
[TBL] [Abstract][Full Text] [Related]
7. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
[TBL] [Abstract][Full Text] [Related]
8. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
10. PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress.
Mazzà D; Infante P; Colicchia V; Greco A; Alfonsi R; Siler M; Antonucci L; Po A; De Smaele E; Ferretti E; Capalbo C; Bellavia D; Canettieri G; Giannini G; Screpanti I; Gulino A; Di Marcotullio L
Cell Death Differ; 2013 Dec; 20(12):1688-97. PubMed ID: 24013724
[TBL] [Abstract][Full Text] [Related]
11. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
[TBL] [Abstract][Full Text] [Related]
12. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
[TBL] [Abstract][Full Text] [Related]
13. The LIM-only protein FHL2 is a negative regulator of E4F1.
Paul C; Lacroix M; Iankova I; Julien E; Schäfer BW; Labalette C; Wei Y; Le Cam A; Le Cam L; Sardet C
Oncogene; 2006 Sep; 25(40):5475-84. PubMed ID: 16652157
[TBL] [Abstract][Full Text] [Related]
14. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
15. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity.
Abida WM; Nikolaev A; Zhao W; Zhang W; Gu W
J Biol Chem; 2007 Jan; 282(3):1797-804. PubMed ID: 17098746
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.
Wang YH; Tsay YG; Tan BC; Lo WY; Lee SC
J Biol Chem; 2003 Jul; 278(28):25568-76. PubMed ID: 12724314
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
18. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
[TBL] [Abstract][Full Text] [Related]
19. p53 stabilization and transactivation by a von Hippel-Lindau protein.
Roe JS; Kim H; Lee SM; Kim ST; Cho EJ; Youn HD
Mol Cell; 2006 May; 22(3):395-405. PubMed ID: 16678111
[TBL] [Abstract][Full Text] [Related]
20. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
Kobet E; Zeng X; Zhu Y; Keller D; Lu H
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
